<figure><img src="image_1.png" /></figure>

Review

# Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus

Annick Barre<fnref n="1" />,*, Els J.M. Van Damme<fnref n="2" />,*, Mathias Simplicien<fnref n="1" />, Hervé Benoist<fnref n="1" /> and Pierre Rougé<fnref n="1" />,*,

Received: 10 October 2020; Accepted: 26 October 2020; Published: 29 October 2020

<figure><img src="image_2.png" /></figure>

check for
updates

**Abstract:** Seaweed lectins, especially high-mannose-specific lectins from red algae, have been identified as potential antiviral agents that are capable of blocking the replication of various enveloped viruses like influenza virus, herpes virus, and HIV-1 in vitro. Their antiviral activity depends on the recognition of glycoprotein receptors on the surface of sensitive host cells—in particular, hemagglutinin for influenza virus or gp120 for HIV-1, which in turn triggers fusion events, allowing the entry of the viral genome into the cells and its subsequent replication. The diversity of glycans present on the S-glycoproteins forming the spikes covering the SARS-CoV-2 envelope, essentially complex type N-glycans and high-mannose type N-glycans, suggests that high-mannose-specific seaweed lectins are particularly well adapted as glycan probes for coronaviruses. This review presents a detailed study of the carbohydrate-binding specificity of high-mannose-specific seaweed lectins, demonstrating their potential to be used as specific glycan probes for coronaviruses, as well as the biomedical interest for both the detection and immobilization of SARS-CoV-2 to avoid shedding of the virus into the environment. The use of these seaweed lectins as replication blockers for SARS-CoV-2 is also discussed.

**Keywords:** seaweed lectins; red algae; mannose-specific lectins; N-acetylgalactosamine-specific lectins; T/Tn-specific lectins; griffithsin; SARS-CoV-2; COVID-19; N-glycosylation; O-glycosylation; high-mannose glycans; glycan probes

## 1. Introduction

The occurrence of lectins, formerly designated as hemagglutinins due to their capacity to agglutinate red blood cells from humans and various animals, in marine seaweeds has been recognized for a long time, following the pioneering works of Boyd et al. [1] and Blunden et al. [2] on British marine algae. The carbohydrate-binding specificity of some of these seaweed lectins, especially high-mannose-specific lectins extracted and purified from red algae (Rhodophyta), has been studied in detail owing to their ability to induce apoptosis in cancer cells [3–7] and block, at least in vitro, the replication of various enveloped viruses such as influenza, herpes, and HIV-1 [8–15].

Griffithsin (GRFT) from the red alga *Griffithsia* sp., exhibited inhibiting properties towards HIV-1 [8]. High-mannose-specific lectins from the red algae *Kappaphycus alvarezii* (KAA-2) [10,13], *Eucheuma serra* (ESA-2) [12], and *Halimeda renschii* (HRL-40) [14] also recognized high-mannose N-glycans (HM-glycans) occurring at the surface of the influenza virus [10–12,14] and HIV-1 [8,11,13]. The high-mannose-specific

<footnote n="1">¹ Institut de Recherche et Développement, Faculté de Pharmacie, UMR 152 PharmaDev, Université Paul Sabatier, 35 Chemin des Maraîchers, 31062 Toulouse, France; annick.barre@univ-tlse3.fr (A.B.); simplicien.mathias@gmail.com (M.S.); herve.benoist@ird.fr (H.B.)</footnote>

<footnote n="2">² Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Coupure links 653, B-9000 Ghent, Belgium; ElsJM.VanDamme@UGent.be</footnote>

<footnote>* Correspondence: pierre.rouge.perso@gmail.com; Tel.: +33-069-552-0851</footnote>
lectin from the green alga *Boodlea coacta* (BCA) [11] interacts more specifically with (Manα1,2)-glycans, especially as the number of terminal branched Manα1,2 is increased. Very similar antiviral properties were identified for the cyanobacterial lectins such as OAA from *Oscillatoria agardhii* [16], cyanovirin-N (CNV-N) from *Nostoc ellipsosporum* [17–21], microvirin MVN from *Microcystis aeruginosa* [22,23], and scytovirin SVN from *Scytonema varium* [24]. Antiviral properties of CNV-N were reported against several viruses including HIV-1 [17], influenza virus [21], herpes virus [18,19], hepatitis C virus [20], and Ebola virus [19]. Obviously, the antiviral activity of high-mannose-specific seaweed and cyanobacterial lectins correlates with their capacity to recognize the high-mannose *N*-glycans associated to different glycoprotein receptors, e.g., hemagglutinin from influenza virus [14], or gp120 from HIV-1 [13], covering the viral envelopes.

Taking into account the antiviral properties and the well known diversity of *N*-glycans decorating the spikes arrayed on the surface of the SARS-CoV-2 envelope, essentially comprised of complex *N*-glycans and high-mannose *N*-glycans [25,26], one can assume that seaweed lectins, especially high-mannose-specific seaweed lectins, can be useful tools as glycan probes for this type of coronavirus (Figure 1).

<figure><img src="image_3.png" /><figcaption>**Figure 1.** Molecular organization of the SARS-CoV-2 envelope (coronavirus credit: Maria Voigt/RCSB PDB). The spikes (colored pale green) protruding at the surface of the virus consist of homotrimers of the S-glycoprotein.</figcaption></figure>

SARS-CoV-2 spikes consist of homotrimers of S-glycoproteins and play a key role in both the recognition and the subsequent membrane fusion events, resulting in the infection of the host cells [27,28]. Spikes occur in different conformations, but the closed conformation seems to occur more frequently at the surface of the viral envelope [29]. The S-glycoprotein consists of two subunits, S1 and S2, and the S1 subunit containing the receptor binding domain (RBD) is responsible for the binding to the angiotensin-converting enzyme 2 (ACE2) receptor. Motions in the RBD that are apparently pH-dependent allow the transition from a closed conformation (all RBD-down state) to an open conformation (all RBD-up state), and this transition is induced or stabilized upon binding of the RBDs to the ACE2 receptors at the surface of the host cells [30]. In turn, this recognition of ACE2 triggers the fusion of the viral envelope to the cell membrane of host cells, which allows the entry of the viral RNA genome into the cells [31]. The S2 subunit that has been proteolytically cleaved from the S1 subunit at a S1-S2 cleavage site of the S-glycoprotein, is responsible for this fusion event [32,33]. Finally, infected cells are now ready for the replication of the virus and the subsequent release of virions out of the dying host cells. This viral cycle is quite common among viruses, but SARS-CoV-2 is different from other closely related viruses in that it specifically recognizes ACE2 proteins as potential receptors, using the RBDs of the S-glycoprotein. This recognition and binding event accounts, at least in part, for the ability of SARS-CoV-2 to preferentially target host cells that are particularly rich in ACE2 protein receptors at the cell surface, such as kidney cells [34].

Due to the high number of high-mannose *N*-glycans of the S-glycoproteins forming the SARS-CoV-2 spikes [25,26,35], high-mannose-specific seaweed lectins appear as relevant glycan probes both for analytical purposes, e.g., the detection or immobilization of the virions, and for biomedical purposes, e.g., preventing the replication and fusion events of SARS-CoV-2. In this review, we present a detailed
analysis of the carbohydrate-binding specificities of seaweed lectins that could be used as glycan probes for the SARS-CoV-2 coronavirus.

## 2. Seaweed Lectins of Various Carbohydrate-Binding Specificities

According to their carbohydrate-binding specificity towards simple sugars, (seaweed) lectins can be classified in five main groups of Man-specific lectins, GlcNAc-specific lectins, Gal/GalNAc-specific lectins, Fuc-specific lectins, and Sia-specific lectins. Until now, the research on seaweed lectins has focused especially on the Man-specific lectins, and these lectins have been characterized in more detail.

### 2.1. Man-Specific Seaweed Lectins

To date, a large number of seaweed lectins have been screened, but only a few lectins have been studied in detail or have been characterized at the molecular/structural level. In spite of these limitations, the amino acid sequences and some structural information have become available for some Man-specific seaweed lectins from the red algae (Rhodophyta), the yellow-green algae (Ochrophyta), and the green algae (Chlorophyta) (Table 1).

<table><caption>**Table 1.** List of Man-specific seaweed lectins.</caption><thead><tr><th>Seaweed Family</th><th>Seaweed Species</th><th>Lectin</th><th>Structural Scaffold</th><th>Ref.</th></tr></thead><tbody><tr><td rowspan="15">Red algae</td><td>Agardhiella subulata</td><td>ASL-1,<br>ASL-2</td><td>β-barrel<br>β-barrel</td><td>[7]</td></tr><tr><td>Carpopeltis flabellata</td><td>CFA</td><td>unknown</td><td>[36]</td></tr><tr><td rowspan="3">Eucheuma amakusaensis</td><td>EAA-1</td><td>β-barrel</td><td rowspan="3">[37]</td></tr><tr><td>EAA-2</td><td>β-barrel</td></tr><tr><td>EAA-3</td><td>β-barrel</td></tr><tr><td rowspan="2">Eucheuma cottonii</td><td>ECA-1</td><td>β-barrel</td><td rowspan="2">[37]</td></tr><tr><td>ECA-2</td><td>β-barrel</td></tr><tr><td rowspan="2">Eucheuma denticulatum</td><td>EDA-1</td><td>β-barrel</td><td rowspan="2">[38]</td></tr><tr><td>EDA-2</td><td>β-barrel</td></tr><tr><td rowspan="2">Eucheuma serra</td><td>ESA-1</td><td>β-barrel</td><td rowspan="2">[39,40]</td></tr><tr><td>ESA-2</td><td>β-barrel</td></tr><tr><td>Gracilaria bursa-pastoris</td><td>GBPL</td><td>unknown</td><td>[41]</td></tr><tr><td>Grateloupia chiangii</td><td>GCL</td><td>β-prism II</td><td>[15]</td></tr><tr><td>Griffthsia sp.</td><td>griffithsin</td><td>β-barrel</td><td>[8]</td></tr><tr><td>Kappaphycus alvarezii</td><td>KAA-2</td><td>β-barrel</td><td>[10]</td></tr><tr><td>Kappaphycus striatum</td><td>KSA-2</td><td>β-barrel</td><td>[38]</td></tr><tr><td>Meristiella echinocarpa</td><td>MEL</td><td>β-barrel</td><td>[42]</td></tr><tr><td rowspan="2">Meristotheca papulosa</td><td>MPA-1</td><td>β-barrel</td><td rowspan="2">[42]</td></tr><tr><td>MPA-2</td><td>β-barrel</td></tr><tr><td rowspan="2">Solieria filiformis</td><td>SfL-1</td><td>β-barrel</td><td rowspan="2">[12]</td></tr><tr><td>SfL-2</td><td>β-barrel</td></tr><tr><td>Solieria robusta</td><td>SrL</td><td>β-barrel</td><td>[3]</td></tr><tr><td>Hydropuntia (Gracilaria) fisheri</td><td>HFA</td><td>β-sandwich</td><td>[43]</td></tr><tr><td>Porphyra umbilicalis</td><td>NgL</td><td>β-sandwich</td><td>[44]</td></tr><tr><td rowspan="5">Yellow-green algae</td><td>Nannochloropsis gaditana</td><td>BU14</td><td>β-sandwich</td><td>[45]</td></tr><tr><td>Boodlea coacta</td><td>BCA</td><td>β-prism II</td><td>[11,46]</td></tr><tr><td>Bryopsis plumosa</td><td>BPL-2</td><td>MFP2-like scaffold</td><td>[47]</td></tr><tr><td>Enteromorpha prolifera</td><td>EPL-1/2</td><td>unknown</td><td>[48]</td></tr><tr><td>Halimeda renschii</td><td>HRL40-1/2</td><td>unknown</td><td>[14]</td></tr><tr><td rowspan="2">Green algae</td><td>Ostreococcus tauri</td><td>OtL</td><td>β-sandwich</td><td>[49]</td></tr><tr><td></td><td></td><td></td><td></td></tr></tbody></table>
Man-specific seaweed lectins belong to a few well defined protein families which have been previously identified and characterized for the molecular organization of their protomers, especially in plants [50]:

- The GNA (*Galanthus nivalis agglutinin*)-related family of lectins consists of protomers organized in a β-prism II or β-trefoil. The red alga *Grateloupia chiangii* lectin (GCL) and the green alga *Boodlea coacta* lectin (BCA) present this type of structural organization.

- The jacalin-related family of lectins contains protomers organized in a β-prism I or β-barrel. Most of the mannose-specific lectins from red algae belong to this group of lectins, e.g., griffithsin and lectins from the genera *Gracilaria*, *Eucheuma*, *Grateloupia*, *Kappaphycus*, and *Solieria*.

- The legume lectin-related family is made of protomers organized in a β-sandwich or jelly roll fold (two β-sheets). This structural scaffold occurs in a few lectins from the genera *Hydropuntia* (red algae), *Nannochloropsis* (yellow-green algae), *Ostreococcus* (green algae), and *Porphyra* (red algae).

Man-specific seaweed lectins readily accommodate Man, oligomannosides, and high-mannose type glycan chains. In addition, most of them recognize the tri-mannosyl core Manα1,3-Manα1,6-Man occurring in both N-acetyllactosaminic type glycans and high-mannose type glycans.

### 2.1.1. Man-Specific Seaweed Lectins With a β-Prism II Structure

The *Grateloupia chiangii* lectin (GCL) offers a nice example of a Man-specific red alga lectin with a β-prism II structure. The β-prism II scaffold consists of three bundles of four antiparallel β-strands arranged into a flattened trefoil-shaped structure around a central pseudoaxis. The GCL lectin dimer consists of two covalently linked swapped protomers organized in a β-trefoil in such a way that both protomers become oriented almost orthogonally (Figure 2A). Each protomer contains three carbohydrate-binding sites (CBS-I, CBS-II, and CBS-III) that form a shallow depression which accommodates a Man residue via a network of six hydrogen bonds involving Q31, N35, Y39 residues, and stacking interactions between the aromatic residues Y39 and Y56 and the pyranose ring of mannose (CBS-I) (Figure 2B,C). The green algae group, *Boodlea coacta*, also contains a Man-specific lectin (BCA) with a β-prism II structure [46].

<figure><img src="image_4.png" /><figcaption>**Figure 2.** Molecular modeling of lectin from *Grateloupia chiangii*. (A) Lateral view of the ribbon diagram of the modeled lectin from *Grateloupia chiangii* (GCL), in complex with mannose (M, colored purple). The lectin dimer consists of the association of two differently oriented protomers exhibiting a β-trefoil fold. Man residues occupying the three CBS of the second protomer are represented. (B) Network of hydrogen bonds (black dashed lines) anchoring Man (M) to the amino acid residues Q31, N35, and Y39, forming the CBS-I of GCL. Aromatic residues Y39 and Y56 participating in stacking interactions with the pyranose ring of Man, are colored orange. (C) Molecular surface (colored slate green) at the CBS-I of GCL, forming a depression (delineated by a yellow dashed line) harboring the Man (M, colored purple) linked by a network of hydrogen bonds (black dashed lines) to Q31, N35, and Y39 residues, and stacking interactions with Y39 and Y56 residues (colored orange).</figcaption></figure>

### 2.1.2. Man-Specific Seaweed Lectins with a β-Sandwich Structure

The *Porphyra umbilicalis* lectin (PUL) illustrates the β-sandwich organization of the lectin protomer, resulting from the covalent superposition of two strands of β-sheets connected by more or less extended
loops, forming the front and back faces of the β-sandwich, respectively (Figure 3A,B). This type of structural organization is very common in plant lectins belonging to the Fabaceae or Leguminosae family, such as Con A [51], pea [52], and lentil [53] lectins. Animal lectins, such as the LMAN1/ERGIC-53 protein [54] or the VIP36 protein [55], also possess a β-sandwich structure. A few amino acid residues belonging to the loops connecting both strands of β-sheets in the β-sandwich structure (Figure 3B), form the CBS which accommodates Man and dimannosides via a network of hydrogen bonds with residues N115, T137, S138, E207 and H210, and stacking interactions with the aromatic residues F211 and F213 (Figure 3C). The CBS appears as a shallow depression at the molecular surface of the lectin, in which the Man units become anchored (Figure 3D). Two other Man-specific lectins with a β-sandwich structure have been identified in the green-yellow alga *Nannochloropsis gaditana* (BU14), and in the green alga *Ostreococcus tauri* (OtL) [49] (Table 1).

<figure><img src="image_5.png" /><figcaption>**Figure 3.** Molecular modeling of *Porphyra umbilicalis* lectin. (A,B) Back face (A) and lateral view (B) of the ribbon diagram of the modeled Porphyra umbilicalis lectin (PUL) in complex with a dimannoside Manα1,2Man (M, colored purple). The calcium ion is colored green. The front (F) and back (B) faces of the β-sandwich are indicated in B. (C) Network of hydrogen bonds (black dashed lines) anchoring the dimannoside Manα1,2Man (M) to the amino acid residues forming the CBS of the PUL. Aromatic residues F113 and F211 interacting with the dimannoside by stacking interactions, are colored orange. (D) Molecular surface (colored slate green) at the CBS of PUL forming a depression (delineated by a yellow dashed line) harboring the dimannoside (M, colored purple) linked by a network of hydrogen bonds (black dashed lines) to N115, T137, S138, E207, and H210 residues, and stacking interactions with F113 and F211 residues (colored orange). The calcium ion is colored green.</figcaption></figure>

### 2.1.3. Man-Specific Seaweed Lectins with a β-Prism I Structure

Griffithsin, the Man-specific jacalin-related lectin firstly isolated and characterized from the red alga *Griffithsia* sp., is the prototype of a group of giffithsin-like lectins occurring in red algae, especially in the genera *Agardhiella*, *Eucheuma*, *Gracilaria*, *Kappaphycus*, *Meristiella*, *Meristotheca*, and *Solieria* (Table 1). The domain-swapped griffithsin consists of two non-covalently associated domains exhibiting a β-barrel structure built up from three four-stranded antiparallel β-sheets (Figure 4A). Loops connecting the β-sheets form three CBS at the top of the β-barrel (Figure 3A,B). A front view of the β-barrel shows that the CBS adopt a triangular pattern at the top of each protomer (Figure 4D).

Each of the three CBS accommodates Man via a network of nine hydrogen bonds with G26, S27, Y28, D30, and G44 residues (for the 1st CBS), and two additional stacking interactions with aromatic residues Y28 and Y110 (Figure 4C). The CBS form a shallow depression largely open at the molecular surface of the lectin, in which Man is anchored by hydrogen bonds and hydrophobic interactions (Figure 4D).
<figure><img src="image_6.png" /><figcaption>**Figure 4.** Molecular modeling of griffithsin. (A,B) Lateral (A) and front view (B) of the ribbon diagram of the domain-swapped griffithsin, in complex with mannose (M) (PDB code 2GUD). (C) Network of hydrogen bonds (black dashed lines) anchoring mannose (M) to the amino acid residues forming the CBS of griffithsin. Aromatic residues Y28 and Y110 participating in stacking interactions with the pyranose ring of Man, are colored orange. (D) Molecular surface (colored slate green) at the CBS of griffithsin forming a depression (delineated by a yellow dashed line) harboring the Man (M, colored purple) linked by a network of hydrogen bonds (black dashed lines) to G26, S27, Y28, D30, and G44 residues, and stacking interactions with Y28 and Y110 residues (colored orange).</figcaption></figure>

The CBS of griffithsin also accommodates dimannosides, e.g., Manα1,6Man, via a similar network of 8 hydrogen bonds and stacking interactions with the Y28 and Y110 residues, but the second Man unit located at the reducing end of the disaccharide does not participate in the interaction (Figure 5A,B). A front view of the CBS shows the absence of contact of the second Man of the dimannoside with the lectin (Figure 5C).

<figure><img src="image_7.png" /><figcaption>**Figure 5.** Molecular modeling of griffithsin. (A) Front view of the ribbon diagram of a domain of griffithsin, in complex with dimannoside Manα1,6Man (M, colored purple) (PDB code 2HYQ). (B) Network of hydrogen bonds (black dashed lines) anchoring the dimannoside (M) to the amino acid residues forming the CBS of griffithsin. Aromatic residues Y28 and Y110 participating in stacking interactions with the dimannoside, are colored orange. (C) Molecular surface (colored slate green) at the CBS of griffithsin forming a depression (delineated by a yellow dashed line) harboring the dimannoside (M, colored purple) linked by a network of hydrogen bonds (black dashed lines) to G26, S27, Y28, D30 and G44 residues, and stacking interactions with Y28 and Y110 residues (colored orange). Note the absence of contact between the second Man residue of the dimannoside and the CBS of griffithsin.</figcaption></figure>

According to the triangular disposition of the three CBS at the top of the griffithsin protomers, both CBS can participate in the binding of a complex octasaccharide (Man<sub>8</sub>) to the lectin (Figure 6A). The Man8 interact with the lectin via a network of 18 hydrogen bonds with residues G12 (first CBS), G66, D67, Y68, D70 (second CBS), and G90, G108, D109, Y110, and D112 (third CBS), together with stacking interactions with aromatic residues Y28 (first CBS), Y68 (second CBS), and Y110 (third CBS) (Figure 6B). A front view of the protomer linked to Man<sub>8</sub> oligosaccharide, shows that the second and third CBS of griffithsin play a major role in the interaction with the octamannoside (Figure 6C).
<figure><img src="image_8.png" /><figcaption>**Figure 6.** Anchoring of Man~8~ to griffithsin. (A) Lateral view of the ribbon diagram of griffithsin in complex with a high-mannose branched chain (M~8~, colored purple) (PDB code 3LL2). (B) Network of hydrogen bonds (black dashed lines) anchoring M~8~ to the amino acid residues forming CBS-I (G12), CBS-II (G66, D67, Y68, D70), and CBS-III (G90, G108, D109, Y110, D112) of griffithsin. Aromatic residues Y28, Y68 and Y110 participating in stacking interactions with the M~8~, are colored orange. (C) Molecular surface (colored slate green) at the CBS-II and CBS-III of griffithsin, forming a depression (delineated by a yellow dashed line) harboring M~8~ (M~8~, colored purple) linked by a network of hydrogen bonds (black dashed lines) to G12, G66, D67, Y68, D70, G90, G108, D109, and D112 residues, and stacking interactions with Y28, Y68, and Y110 residues (colored orange).</figcaption></figure>

The carbohydrate-binding specificity of another Man-specific lectin with a β-prism I structure from the red alga *Kappaphycus alvarezii* (KAA-2) towards high-mannose glycans, has been studied in detail by Sato et al. [10]. The high-mannose glycan-binding activity of the lectin was measured towards a series of bi- and tri-antennary branched high-mannose glycans (Figure 7).

<figure><img src="image_9.png" /><figcaption>**Figure 7.** Structure of the high-mannose type N-glycans assayed by Sato et al. (2011) to measure the oligosaccharide-binding specificity of KAA-2 from the red alga *Kappaphycus avalvarezii*. The high-mannose N-glycans are aligned according to their decreasing binding activity (expressed as %) towards KAA-2 (adapted from [10]). Symbols used to represent N-glycans: blue squares: N-acetylglucosamine, green circles: mannose.</figcaption></figure>

Docking of a pentamannoside (Man~5~) to the modeled KAA-2 lectin, showed the existence of four CBS located at both ends of the β-barrel forming each protomer of the KAA-2 dimer (Figure 8A). The CBS accommodates the pentamannoside via a network of 14 hydrogen bonds with Q9, G11, G12, R96, E124, G125 and P126 residues, completed by an additional stacking interaction with the aromatic W10 residue (Figure 8B,C). All the Man units of Man~5~ participate in the binding to the lectin.
<figure><img src="image_10.png" /><figcaption>**Figure 8.** Molecular modeling of *Kappaphycus alvarezii lectin*. (A) Lateral view of the ribbon diagram of the modeled KAA-2 from *Kappaphycus alvarezii*, in complex with a pentamannoside chain (M₅, colored purple). (B) Network of hydrogen bonds (black dashed lines) anchoring M₅ to the amino acid residues Q9, G11, G12, R96, E124, G125 and P126 forming the CBS (red dashed circle) of KAA-1. The aromatic residue W10 which also participates in stacking interaction with M₅, is colored orange. (C) Molecular surface (colored slate green) at the CBS of KAA-2, forming a large depression (delineated by a yellow dashed line) harboring M₅ (M₅, colored purple) linked by a network of hydrogen bonds (black dashed lines) to Q9, G11, G12, R96, E124, G125 and P126 residues, and a stacking interaction with W10 residue (colored orange).</figcaption></figure>

Mannose-specific lectins closely-related to griffithsin, which similarly accommodate Man and oligomannosides, have been characterized in blue green algae (cyanobacteria), e.g., cyanovirin-N (CV-N) from the cyanobacterium *Nostoc ellipsosporum* [17], microvirin MVN from *Microcystis aeruginosa* [22,23], scytovirin SVN from *Scytonema varium* [24], and the *Oscillatoria agardhii* agglutinin OAA [16]. All of these cyanobacterial lectin domains also consist of a β-barrel structure [9].

## 2.2. *Seaweed Lectins with GalNAc/T/Tn- and Neu5Ac-Specificity*

Other seaweed lectins display a quite different binding-specificity towards GalNAc and T/Tn antigen (Table 2) and towards Neu5Ac/sialic acid ending N-glycans of the N-acetyllactosaminic type (Table 3). However, at present no sequence and structural information is available to get an insight into the molecular aspects of their carbohydrate-binding specificity.

<table><caption>**Table 2.** List of GalNAc/T/Tn-specific seaweed lectins.</caption><thead><tr><td>Seaweed Family</td><td>Seaweed Species</td><td>Lectin</td><td>Structural Scaffold</td><td>Ref.</td></tr></thead><tbody><tr><td>Rhodophyceae</td><td>Aglaothamnion oosumiense</td><td>AOL1</td><td>unknown</td><td>[56]</td></tr><tr><td>Chlorophyceae</td><td>Codium fragile</td><td>CFL</td><td>unknown</td><td>[57,58]</td></tr></tbody></table>

<table><caption>**Table 3.** List of Neu5Ac-specific seaweed lectins.</caption><thead><tr><td>Seaweed Family</td><td>Seaweed Species</td><td>Lectin</td><td>Structural Scaffold</td><td>Ref.</td></tr></thead><tbody><tr><td rowspan="3">Rhodophyceae</td><td>Gracilaria tikvahiae</td><td>GTL</td><td>unknown</td><td>[59]</td></tr><tr><td>Palmaria palmata</td><td>PPL</td><td>unknown</td><td>[60]</td></tr><tr><td>Solieria chordalis</td><td>ScL</td><td>β-barrel</td><td>[61]</td></tr><tr><td>Phaeophyceae</td><td>Fucus vesiculosus</td><td>? *</td><td>unknown</td><td>[62]</td></tr></tbody></table>

<footnote>* The protein nature of the so-called *Fucus vesiculosus* lectin needs further confirmation.</footnote>
### 3. Structural Organization and Glycosylation of S Glycoproteins Forming the Spikes of SARS-CoV-2 Virus

The spikes arrayed on the surface of SARS-CoV-2, each result from the non-covalent association of three similar S-glycoproteins in an homotrimer structural scaffold that protrudes outside the virus surface (Figure 1).

The spike S-glycoprotein consists of a single polypeptide chain of 1273 amino acids (140 kDa), containing 22 potential N-glycosylation sites 17NLT, 61NVT, 74NGT, 122NAT, 149NKS, 165NCT, 234NNIT, 282NNGT, 331NIT, 343NAT, 603NTS, 616NCT, 657NNS, 709NNS, 717NFT, 801NFS, 1074NFT, 1098NGT, 1134NNT, 1158NHT, 1173NAS, 1194NES (seven potential N-glycosylation sites 17NLT, 603NTS, 657NNS, 1134NNNT, 1158NHT, 1173NAS and 1194NES, are apparently not glycosylated) and three O-glycosylation sites T323, S325 and T678 are actually glycosylated [25,26,35].

As shown below the complete amino acid sequence of the S glycoprotein of SARS-CoV-2 is made of two S1 and S2 subunits. The RBD of subunit S1 is highlighted in green and the S1/S2 cleavage site for cathepsin and serine protease TMPRSS2 is highlighted in red. All the N-glycosylation sites NXT/NXS are highlighted in dark blue and the O-glycosylation sites are shown in bold letters highlighted in yellow:

VNLTTRTQLPPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNCTKRFDNPVLP
FNDGVYFASTEKSNIIRGWIFGTTLDSKTQSSLIVNNATNVVIKVCEFQFCNDPFLGVYVHKNNSKSWMESEFR
VYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFALEPLVDLPI
GINNTRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNE NGTITDAVDCALDPLSETKCTLK
SFTVEKGIYQTSNFRVQPTESIVRFINLTNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTF
KCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDFTGCVIAWNSNNLDSKVGGNYN
YLYRLFRKNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLOSYGFQPTNGVGYQPYRVVLSFELLHAPAT
VCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVS
VITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAG
ICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTTEILPVSMTKTSVDCTMYI
CGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKR
SFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPPLLTDEMIAQYTSALLAGTITSGWTF
GAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNT
LVKQLSSNFGAISSVLNDILSRLDPPEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVL
GQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHF PREGVFVSNGTTHWFVTQR
NFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQ
KEIDRLNEVAKNLNESLIDLQELGKYEQGSGYIPEAPRDGQAYVRKDGEWVLLSTFLGRSLEVLFQGPGHHHH
HHHHSAWSHPQFEKGGSGGGGSGGSAWSHPQFEK

A detailed study of the N- and O-glycans attached to the potential N- and O-glycosylation sites decorating the amino acid sequence of the S-glycoprotein of SARS-CoV-2 (Figure 9), revealed that almost all the putative N-glycosylation sites are occupied by a glycan chain, with the exception of the seven potential N-glycosylation sites 17NLT, 603NTS, 657NNS, 1134NNT, 1158NHT, 1173NAS and 1194NES. All potential O-glycosylation sites T323, S323 and T678, exhibited core-1 type O-glycans [25,26].

A large diversity was observed in the types of N-glycans present at the potential N-glycosylation sites:

- N-glycosylation sites 149NKS, 165NCT, 282NGT, 657NNS, 709NNS, 801NFT, 1074NGT, 1098NGT and 1194NES (often not glycosylated), are almost exclusively occupied by often sialylated, bi-, tri- and tetra-antennary N-glycans of the complex type (Figure 10)

- N-glycosylation sites 61NVT, 331NIT, 343NAT and 616NCT, are almost exclusively occupied by N-glycans of the high-mannose type (Figure 10)

- The remaining N-glycosylation 74NGT, 122NAT, 234NIT and 717NFT, contain a mix of N-glycans of both types, complex N-glycans and high-mannose N-glycans (Figure 10)

- Both O-glycosylated sites T323, S325, harbor core-1 mucin type O-glycans: GalNAc, T-antigen GalNAcGal, sialylated T-antigen GalNAcGalNeuAc₂, and core-2 sialylated O-glycans GalNAcGalNeuAc(GlcNAcGal), and GalNAcGalNeuAc(GlcNAcGalNeuAc) (Figure 10)
<figure><img src="image_11.png" /><figcaption>**Figure 9.** Structure of S-glycoprotein of SARS-CoV-2. (A) Ribbon diagram of the heavily glycosylated S-glycoprotein of SARS-CoV-2 (PDB code 6VXX). The RBD bearing 2 *N*-glycans is colored green and circled by a red dotted line. *N*-glycans (biantennary core (GlcNAc)₂(Man)₅) are colored cyan. (B) Molecular surface representation of the glycosylated S-glycoprotein of SARS-CoV-2. The molecular surface of RBD is colored green.</figcaption></figure>

Bi- and tri-antennary glycans are predominantly represented, across all categories of the complex *N*-glycans and high-mannose *N*-glycans. Moreover, high-mannose glycans predominantly occur at the top of the S-glycoprotein whereas complex *N*-glycans are localized at the bottom of the glycoprotein, close to the viral envelope surface.

An interesting note is that the RBD (highlighted in green in both the amino acid sequence and tridimensional structure of the S-glycoprotein of SARS-CoV-2), only contains two *N*-glycosylation sites, 331NIT and 343NAT, predominantly occupied by high-mannose *N*-glycans that should be readily accessible to Man-specific seaweed and cyanobacterial lectins.

Most of the complex glycans are sialylated on their Gal residues. Therefore, one can assume that Neu5Ac-specific lectins that have been identified in red algae (Table 3), would recognize the sialylated glycans of SARS-CoV-2. Conversely, the O-glycosylation sites T323 and S325, are rather buried at the top of the S-glycoprotein, in such a way that the O-glycans are not identified as key targets for the binding of GalNAc/T-Tn-specific lectins to the S-glycoprotein trimer. However, O-glycosylation site T678 is pretty well exposed at the bottom of the S-glycoprotein and therefore, should be accessible to the GalNAc/T-Tn-specific lectins. Accordingly, seaweed lectins with the corresponding specificity should not be relevant glycan probes for SARS-CoV-2, except for the single exposed O-glycosylation site T678 (Table 2).

The apparent diversity in glycosylation identified in SARS-CoV-2 and, especially the complex glycans and high-mannose *N*-glycans, has also been reported for the SARS-CoV virus [63], suggesting Man-specific seaweed lectins can be used as glycan probes for other pathogenic coronaviruses.

The three-dimensional structure of the spike RBD of the S-glycoprotein and the S-glycoprotein monomer, has been solved at atomic resolution, using either X-ray radiocrystallography or cryo-electron microscopy (Table 4). The three-dimensional organization of the spike of SARS-CoV-2 has been also solved in the prefusion conformation, essentially by electron microscopy at lower resolution (Table 4). All these structures confirm the high degree of glycosylation of the S-glycoprotein of SARS-CoV-2 and the lower glycosylation of the RBD, which possesses only two well-exposed sites for *N*-glycosylation (331NIT and 343NAT) and two rather buried sites for O-glycosylation (T323 and S325) (Figure 11). In addition to RBD, the highly glycosylated *N*-glycans associated to 234NIT and
282NGT, would play a prominent role in the binding of SARS-CoV-2 to ACE2 receptors of the host cells [25,26,35].

<figure><img src="image_12.png" /><figcaption>**Figure 10.** Diversity of the N-glycans of the biantennary complex type (left frame) and high-mannose type (upper right frame), and O-glycans (lower right frame), identified in the S-glycoprotein forming the spikes at the surface of the SARS-CoV-2 envelope [26]. Symbols used to represent the N- and O-glycans: blue squares: N-acetylglucosamine (GlcNAc), green circles: mannose (Man), yellow circles: galactose (Gal), red triangle: fucose (Fuc), purple diamonds: sialic acid (Neu5Ac), yellow square: N-acetylgalactosamine (GalNAc).</figcaption></figure>
<table><caption>**Table 4.** List of the RBD (Receptor-binding domain) and S-GPT (S-Glycoprotein trimer) solved by either X-ray radiocrystallography and/or cryo-electron microscopy (Cryo-Em). Tbp: to be published (atomic coordinates available at the PDB but results are unpublished by the authors).</caption><thead><tr><th>RBD/S-GPT</th><th>PDB Code</th><th>RX/Cryo-Em</th><th>Resolution (Å)</th><th>Ref.</th></tr></thead><tbody><tr><td>RBD</td><td>6W41</td><td>RX</td><td>3.084 Å</td><td>[64]</td></tr><tr><td>RBD</td><td>6XC2, 6XC3, 6XC4, 6XC7</td><td>RX</td><td>2.3 Å–3.11 Å</td><td>[65]</td></tr><tr><td>RBD</td><td>6XDG</td><td>Cryo-Em</td><td>3.9 Å</td><td>[66]</td></tr><tr><td>RBD</td><td>6XE1</td><td>RX</td><td>2.75 Å</td><td>[67]</td></tr><tr><td>RBD</td><td>6YLA, 6YM0, 6YOM</td><td>RX, Cryo-Em</td><td>2.42 Å–4.36 Å</td><td>Tbp</td></tr><tr><td>RBD</td><td>6YZ7, 6Z2M, 6ZH9</td><td>RX</td><td>2.71 Å–3.31 Å</td><td>Tbp</td></tr><tr><td>RBD</td><td>6ZCZ, 6ZER, 6ZFO</td><td>RX, Cryo-Em</td><td>2.65 Å–4.4 Å</td><td>[68]</td></tr><tr><td>RBD</td><td>7BWJ</td><td>RX</td><td>2.85 Å</td><td>[69]</td></tr><tr><td>RBD</td><td>7BZ5</td><td>RX</td><td>1.84 Å</td><td>[70]</td></tr><tr><td>RBD</td><td>7C01</td><td>RX</td><td>2.88 Å</td><td>[28]</td></tr><tr><td>RBD</td><td>7C8V</td><td>RX</td><td>2.15 Å</td><td>Tbp</td></tr><tr><td>RBD</td><td>7JMP</td><td>RX</td><td>1.712 Å</td><td>[71]</td></tr><tr><td>S-GPT</td><td>6VYB</td><td>Cryo-Em</td><td>3.2 Å</td><td>[72]</td></tr><tr><td>S-GPT</td><td>6WPT</td><td>Cryo-Em</td><td>3.1 Å–3.7 Å</td><td>[73]</td></tr><tr><td>S-GPT</td><td>6X2A</td><td>Cryo-Em</td><td>2.9 Å–3.6 Å</td><td>[74]</td></tr><tr><td>S-GPT</td><td>6X6P</td><td>Cryo-Em</td><td>3.22 Å</td><td>[29]</td></tr><tr><td>S-GPT</td><td>6X79</td><td>Cryo-Em</td><td>2.9 Å</td><td>[75]</td></tr><tr><td>S-GPT</td><td>6XCN</td><td>Cryo-Em</td><td>3.42 Å–3.66 Å</td><td>[76]</td></tr><tr><td>S-GPT</td><td>6XEY</td><td>Cryo-Em</td><td>3.27 Å</td><td>[77]</td></tr><tr><td>S-GPT</td><td>6XF5,6XF6</td><td>Cryo-Em</td><td>3.45 Å–4.0 Å</td><td>Tbp</td></tr><tr><td>S-GPT</td><td>6XKL</td><td>Cryo-Em</td><td>3.21 Å</td><td>[78]</td></tr><tr><td>S-GPT</td><td>6XLU,6XM0,6XM3,6XM4,6XM5</td><td>Cryo-Em</td><td>2.4 Å–3.1 Å</td><td>[31]</td></tr><tr><td>S-GPT</td><td>6XR8</td><td>Cryo-Em</td><td>2.9 Å</td><td>[79]</td></tr><tr><td>S-GPT</td><td>6XS6</td><td>Cryo-Em</td><td>3.7 Å</td><td>[80]</td></tr><tr><td>S-GPT</td><td>6Z43</td><td>Cryo-Em</td><td>3.3 Å</td><td>Tbp</td></tr><tr><td>S-GPT</td><td>6Z97</td><td>Cryo-Em</td><td>3.4 Å</td><td>[81]</td></tr><tr><td>S-GPT</td><td>6ZDH</td><td>Cryo-Em</td><td>3.7 Å</td><td>[68]</td></tr><tr><td>S-GPT</td><td>6ZGE,6ZGH,6ZGG,6ZGI,6ZHD</td><td>Cryo-Em</td><td>2.6 Å–6.8 Å</td><td>Tbp</td></tr><tr><td>S-GPT</td><td>6ZOX,6ZOY,6ZOZ,6ZP0,6ZP1,6ZP2</td><td>Cryo-Em</td><td>3.0 Å–3.5 Å</td><td>[29]</td></tr><tr><td>S-GPT</td><td>6ZOW,6ZP5, 6ZP7</td><td>Cryo-Em</td><td>3.0 Å–3.3 Å</td><td>[82]</td></tr><tr><td>S-GPT</td><td>6ZWV</td><td>Cryo-Em</td><td>3.5 Å</td><td>[83]</td></tr><tr><td>S-GPT</td><td>7BYR</td><td>Cryo-Em</td><td>3.84 Å</td><td>[84]</td></tr><tr><td>S-GPT</td><td>7CN9</td><td>Cryo-Em</td><td>4.7 Å</td><td>[85]</td></tr><tr><td>S-GPT</td><td>7JJI</td><td>Cryo-Em</td><td>3.6 Å</td><td>[86]</td></tr></tbody></table>

The spikes S-glycoprotein trimers covering the SARS-CoV-2 virions, mediate the binding to the ACE2 receptor through their RBD (S1 subunit), and the subsequent fusion of the viral membrane with the cell membrane (S2 subunit). The spike S-glycoprotein exhibits some flexibility and conformational motions of the S-glycoprotein are pH-dependent [30]. However, neutralizing antibodies readily recognize the closed conformation (all RBD-down) of the spikes, which is highly encouraging for the future development of antibody candidates as potential therapeutic or prophylactic agents (vaccines) against the SARS-CoV-2 [77].
<figure><img src="image_13.png" /><figcaption>**Figure 11.** Surface glycosylation of SARS-CoV-2 virus. (A) Overall structure of SARS-CoV-2 showing the spikes (colored green) arrayed on the surface of the virus (Coronavirus Credit: Maria Voigt/RCSB PDB). (B,D) Sagital views of the ribbon diagram (B) and the molecular surface (D), showing the structural organization of the spike (PDB code 6ZGE). The three S-glycoproteins forming the SARS-CoV-2 spike are colored yellow, pink, and purple, respectively. The RBD in each S-glycoprotein is colored green. (C,E) Front views of the ribbon diagram (C) and the molecular surface (E), showing the structural organization of the spike. N-glycan chains occupying the putative N-glycosylation sites in the three S-glycoproteins, are colored cyan and represented in spheres.</figcaption></figure>

4. Man-Specific Seaweed Lectins Interact with *N*-glycans Decorating the S-Glycoprotein from SARS-CoV-2

High-mannose-specific lectins from red algae and BCA from the green alga *Boodlea coacta*, were shown to possess antiviral properties against various enveloped virus including influenza, herpes, and hepatitis C viruses, and HIV-1 (Table 5). In addition, griffithsin exhibited antiviral properties against SARS-CoV coronavirus. Obviously, these antiviral properties depend on the ability of seaweed lectins to specifically recognize and bind high-mannose *N*-glycans that cover the virus envelope.

A detailed study of the binding-activity towards pyridylaminated (PA)-oligosaccharides measured for Man-specific lectins of red algae (KAA-2 from *Kappaphycus alvarezii* [10,13] and HRL-40 from *Halimeda renschii* [14]), green algae (BCA from *Boodlea coacta* [11]) and the cyanobacterium OAA from *Oscillatoria agardhii* [16]), showed that all these lectins readily interact with some of the high mannose *N*-glycans present at the surface of both the influenza virus and HIV-1 envelope, associated to hemagglutinin (influenza virus) or gp120 (HIV-1) glycoproteins (Figure 11). The binding of BCA differs from that measured for other algal lectins due to its preference for the recognition of the Manα1,2 linkage [11]; depending on the number of terminal Manα1,2 that decorate the high-mannose branched glycans of the viral envelope, the binding varies from 0 (n = 0) to 100% (n = 3) (Figure 12).
<table><caption>**Table 5.** List of seaweed lectins tested for their antiviral properties against enveloped viruses possessing exposed glycans.</caption><thead><tr><th>Seaweed Family</th><th>Lectin</th><th>Virus</th><th>Glycan Recognized</th><th>Ref.</th></tr></thead><tbody><tr><td rowspan="7">Rhodophyceae</td><td>ESA-2 (Eucheuma serra)</td><td>Influenza</td><td>High-mannose</td><td>[12]</td></tr><tr><td>GCL (Grateloupia chiangii)</td><td>Influenza<br>Herpes</td><td>High-mannose</td><td>[15]</td></tr><tr><td>Griffithsin (Griffithsia sp.)</td><td>HIV-1<br>Hepatitis C<br>SARS-CoV</td><td>High-mannose</td><td>[8]<br>[9]</td></tr><tr><td>HRL-40 (Halimeda renschii)</td><td>Influenza</td><td>High-mannose</td><td>[14]</td></tr><tr><td>KAA-2 (Kappaphycus alvarezii)</td><td>Influenza<br>HIV-1</td><td>High-mannose</td><td>[10]<br>[13]</td></tr><tr><td>Chlorophyceae</td><td>BCA (Boodlea coacta)</td><td>Influenza<br>HIV-1</td><td>High-mannose</td><td>[11]</td></tr><tr><td rowspan="7">* Cyanobacteria</td><td>MVN (Microcystis aeruginosa)</td><td>HIV-1</td><td>High-mannose</td><td>[22]</td></tr><tr><td>MVL (Microcystis viridis)</td><td>HIV-1</td><td>High-mannose</td><td>[23]</td></tr><tr><td rowspan="5">CV-N (Nostoc ellipsosprum)</td><td>HIV-1<br>Herpes<br>Ebola<br>Hepatitis C<br>Influenza</td><td>High-mannose</td><td>[17,18]<br>[18]<br>[19]<br>[20]<br>[21]</td></tr><tr><td>OAA (Oscillatoria agardhii)</td><td>HIV-1</td><td>High-mannose</td><td>[16]</td></tr><tr><td>SVN (Scytonema varium)</td><td>HIV-1</td><td>High-mannose</td><td>[24]</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr></tbody></table>

<figure><img src="image_14.png" /><figcaption>**Figure 12.** Comparative analysis of the binding activity (expressed as %) of the Man-specific lectins KAA-2 from *Kappaphycus alvarezii*, HRL-40 from *Halimeda renschii*, BCA from the green alga *Boodlea coacta*, and OAA from the blue-green alga (cyanobacterium) OAA from *Oscillatoria agardhii* (adapted from Mu et al. [14] and Sato et al. [11,16]). Symbols used to represent high-mannose glycans: blue squares: N-acetylglucosamine, green circles: mannose. High-mannose glycans identified in the S-glycoprotein of the SARS-CoV-2 are indicated by a red star.</figcaption></figure>

<footnote>* Cyanobacteria lectins with antiviral properties were included.</footnote>
An interesting note is that some of the high-mannose glycans of both the hemagglutinin of the influenza virus and the gp120 of HIV-1 recognized by the lectins, also decorate the S-glycoprotein forming the spikes occurring at the surface of the SARS-CoV-2 envelope. Accordingly, the algal Man-specific lectins should similarly interact with the SARS-CoV-2 through the recognition of their spike S-glycoproteins. In this respect, griffithsin (GRFT) was shown to inhibit both the replication and cytopathy of the coronavirus SARS-CoV [36].

Looking at the high-mannose type glycans associated to the glycosylation sites N61, N77 (absent from the 3D structure of the S-glycoprotein monomer (PDB code 6VXX)), N122, N234, N331, N343, N616 and N717 occupied by the high-mannose glycans recognized by the Man-specific lectins KAA-2 (*Kappaphycus alvarezii*), HRL-40 (*Halimeda ronschii*), BCA (*Boodlea coacta*) and OAA (*Oscillatoria agadhii*), shows they are the best exposed at the surface of the S-glycoprotein monomer (Figure 13A,B). This is particularly true for the high-mannose glycans specifically recognized by the Manα1,2-specific lectin BCA, which are almost exclusively localized in the external/upper part of the S-glycoprotein monomer (Figure 13B).

<figure><img src="image_15.png" /><figcaption>**Figure 13.** Glycosylation pattern of the monomeric S-glycoprotein of SARS-CoV-2. (A) High-mannose type glycans (colored yellow) of the monomeric S-glycoprotein of SARS-CoV-2 susceptible to be specifically recognized by Man-specific lectins KAA-2 and HRL-40 from the red algae *Kappaphycus alvarezii* [10,13] and *Halimeda ronschii* [14], and OAA from the blue-green alga (cyanobacterium) *Oscillatoria agarddhii* [16], are well exposed at the top of the protein. Other complex N-glycans decorating the monomer weakly or not recognized by the lectins, are colored cyan. (B) High-mannose type glycans (colored yellow) of the monomeric S-glycoprotein of SARS-CoV-2 susceptible to be specifically recognized by the Manα1,2-specific lectin BCA from the green alga *Boodlea coacta* [11]. Other complex N-glycans decorating the monomer weakly or not recognized by BCA, are colored cyan.</figcaption></figure>

A front view of the trimeric S-glycoprotein of SARS-CoV-2 clearly shows that most of the high-mannose recognized by lectins KAA-2, HRL-40, BCA and OAA, are nicely exposed at the surface of the trimer and are thus readily available for interacting with Man-specific seaweed lectins (Figure 14).
<figure><img src="image_16.png" /><figcaption>**Figure 14.** Glycosylation of trimeric S-glycoprotein of SARS-CoV-2. (A) Front view of the trimeric S-glycoprotein of SARS-CoV-2 showing the high-mannose type glycans (colored yellow) specifically recognized by Man-specific lectins KAA-2 and HRL-40 from the red algae *Kappaphycus alvarezii* [10,13] and *Halimeda renschii* [14], and OAA from the blue-green alga (cyanobacterium) *Oscillatoria agardhhii* [16]. Other complex N-glycans decorating the monomer weakly or not recognized by the lectins, are colored cyan. (B) Front view of the trimeric S-glycoprotein of SARS-CoV-2 showing the high-mannose type glycans (colored yellow) specifically recognized by the Manα1,2-specific lectin BCA from the green alga *Boodlea coacta* [11]. Other complex N-glycans decorating the monomer weakly or not recognized by BCA, are colored cyan.</figcaption></figure>

**5. Interaction of Other Seaweed Lectins with Different Specificities with the S-Glycoprotein from SARS-CoV-2**

Due to the diversity of the glycans decorating the S-glycoprotein of SARS-CoV-2, namely (sialylated) N-glycans of the complex type and O-glycans, seaweed lectins with different specificities should bind to the spikes covering the viral envelope. In this respect, seaweed lectins that specifically recognize GalNAc and the T/Tn antigens (O-glycans) and seaweed lectins specific for terminal Neu5Ac residues, could interact with the S-glycoprotein of SARS-CoV-2 (Table 2). Looking at the localization of both types of glycans at the surface of the S-glycoprotein, shows that O-glycans are attached to the rather buried T323 and S325 residues of S-glycoprotein, that most probably prevents their recognition by GalNAc/T/Tn-specific seaweed lectins [25]. However, another more exposed O-glycosylation site has been identified at T678 [26] (Figure 15). Thus, with the exception of O-glycan site T678 that could be recognized by GalNAc/T-Tn-specific seaweed lectins, only Neu5Ac-specific seaweed lectins could readily interact with the sialylated complex type N-glycans well exposed at the surface of the S-glycoprotein, even though most of them are located at the bottom of the S-glycoprotein and thus, are less accessible to the lectins.
<figure><img src="image_17.png" /><figcaption>**Figure 15.** Ribbon diagram of the monomeric S-glycoprotein of SARS-CoV-2 showing the buried character of the O-glycosylated T323 and S325 amino acid residues (red dashed circle). High-mannose type glycans recognized by Man-specific seaweed lectins are colored yellow. Another exposed O-glycosylated T678 occurs in the S-glycoprotein (red arrow). Other often sialylated complex type N-glycans, well exposed at the surface of the S-glycoprotein monomer, are colored blue.</figcaption></figure>

**6. Bioinformatics**

The atomic coordinates of griffithsin GRFT from *Griffithsia* sp., including the unliganded lectin (PDB code 2GTY) [87], and lectin complexed to mannose (PDB code 2GUD) [87], 6α-mannobiose (PDB code 2HYQ) [88] and high-mannose branched carbohydrate (PDB code 3LL2) [89], were taken from the Protein Data Bank PDB (http://www.rcsb.org/pdb/) [90]. Similarly, the atomic coordinates of the unliganded and complexed to α3, α6-mannopentaose forms of the cyanobacterial Man-specific lectin BOA from *Burkholderia oklahomensis* (PDB code 4GU8 and 4GK9) [91] and the unliganded form of OAA from *Oscillatoria agardhii* (PDB code 3OBL) [92] were also obtained from the PDB.

Homology modeling of other lectins including the β-prism II folded GCL from *Grateloupia chiangii* [15], the β-barrel folded KAA-2 from *Kappaphycus alvarezii* [10], and the β-sandwich folded NgL from *Porphyra umbilicalis* [44], was performed with the YASARA Structure program [93] using various protein templates from the PDB, depending on the overall structural scaffold to which they belong. PROCHECK [94], ANOLEA [95], and the calculated QMEAN scores [96,97], were used to assess the geometric and thermodynamic qualities of the three-dimensional models.

Docking of simple sugars and oligosaccharides was performed with YASARA and SwissDock [98]. Hydrophilic/hydrophobic regions at the surface of the lectins were calculated and displayed with Chimera [99]. Molecular cartoons were drawn with Chimera [99] and YASARA [93].

**7. Discussion**

The S-glycoprotein on the surface of the SARS-CoV-2 virus is a highly glycosylated protein. Due to the exposed localization of high-mannose glycans at the top of the S-glycoprotein trimers many of these glycans are readily accessible to carbohydrate-binding proteins. Seaweed lectins represent well adapted glycan probes for the specific recognition of this type of viruses. In this respect, the Man-specific lectin griffithsin (GRFT) of the red alga *Griffithsia* sp., readily recognized the high mannose N-glycans located on the very similarly glycosylated SARS-CoV S-glyco-protein [9,63]. More generally, in agreement with
their capacity to specifically recognize high-mannose glycoprotein targets exposed at the surface of enveloped viruses, e.g., hemagglutinin of influenza virus, gp120 of HIV-1 or the spike S-glycoprotein of SARS-CoV and SARS-CoV-2, Man-specific seaweed lectins can interfere with the mechanisms allowing the infectious viruses to recognize the corresponding receptors and trigger the fusion events necessary for entering the susceptible cells. As previously reported [9], GRFT was shown to inhibit both the replication and cytopathy of the closely-related coronavirus SARS-CoV. Accordingly, other Man-specific seaweed lectins could act as blockers, at least in vitro, of the replication for the SARS-CoV-2 virus, and display antiviral properties as already shown for cyanobacterial Man-specific lectins towards a broad range of enveloped viruses including influenza virus, Ebola virus, herpes virus, hepatitis C virus and HIV-1.

Moreover, the binding of seaweed lectins to SARS-CoV-2 virus could be applied in biomedical research, e.g., using Man-specific seaweed lectins (1) for detection purposes of the virus on various contaminated surfaces such as doorknobs or furniture elements, (2) as an efficient barrier to avoid the shedding into the environment of contaminating virions and, (3) as control reagents for the occurrence of viral particles in biotic/abiotic samples. Depending on the case, whether properly labelled, e.g., fluorochrome-labelled, Man-specific seaweed lectins could be used directly as glycan probes or unlabelled lectins could be further detected using properly labelled, e.g., fluorochrome-labelled, specific anti-lectin antibodies.

The antiviral properties of Man-specific seaweed lectins and the application of these lectins as blocking agents for the replication of enveloped viruses still requires more investigation. So far, the antiviral properties of Man-specific seaweed lectins, have been demonstrated essentially in in vitro conditions (Table 5). Indeed, only few studies have shown to block the replication of SARS-CoV and other coronaviruses in vivo [100]. O’Keefe et al. (2010) reported on the use of GRFT to prevent the SARS-CoV infection both in vitro and in vivo, and showed that GRFT treatment reduces mortality and morbidity in a lethal infection mouse model [100]. Millet et al., (2016), further pointed out the inhibitory effect of GRFT towards Middle East respiratory syndrome coronavirus MERS-CoV [101] Time-course experiments revealed that GRFT inhibits MERS-CoV infection at the early step when the virus binds the host cells. Next to seaweed lectins, closely related plant lectins with different carbohydrate-binding specificities have been investigated in vitro for their antiviral activity against SARS-CoV and another coronavirus FIPV, responsible for feline infectious peritonitis [102]. Although plant lectins specific for Gal, GalNAc and GlcNAc, exhibited some antiviral activity, a much higher antiviral activity towards both coronaviruses was reported especially for Man-specific lectins belonging to the family of GNA-related lectins, such as GNA from *Galanthus nivalis* (snowdrop), NPA from *Narcissus pseudonarcissus* (daffodil) and APA from *Allium porrum* (leek). In addition, two targets for these Man-specific lectins in the replication cycle of SARS-CoV have been identified, one in the early phase of the replication cycle during viral attachment, and a second target at the end of the infection cycle [102]. More recently, the lectin FRIL from hyacinth bean (*Lablab purpureus*), which specifically recognizes N-glycans of the complex type occurring on the surface of coronavirus envelope, was demonstrated to neutralize SARS-CoV-2 and prevent both viral protein production and cytopathic effects in host (mice) cells [90].

At the molecular level, the mechanism of action for Man-specific lectins is primarily referred to a masking effect of the molecular surface of S-glycoprotein RBDs due to their interaction with the Man-containing glycans, thus hampering the proper attachment of the virions to the host cell receptors and preventing the viral replication. However, the identification of a second target for HHA, the Man-specific lectin from *Hippeastrum hybridum*, at the end of the SARS-CoV infection cycle [102], suggests that Man-specific lectins interfere not only with the virus entry in the host cells but also with the virus release from the host cells. The spike S-glycoprotein most probably is the main glycan target for Man-specific lectins but the specific recognition of other Man-containing targets cannot be excluded. In this respect, the heavily glycosylated ACE2 receptor could also serve as relevant target for Man-specific lectins.
Although lectins remain attractive anti-coronavirus candidates, at present it remains difficult to correctly assess the actual role of these natural compounds in the therapeutic armamentarium, to fight against SARS-CoV-2, the coronavirus responsible for the highly transmissible infectious COVID-19 [103–106].

**Author Contributions:** A.B., M.S. and H.B., provided the bibliographic information and analyses. P.R. performed the molecular modeling and provided the molecular cartoons and the docking pictures. E.J.M.V.D. and P.R. wrote the review. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflict of interest.

**Abbreviations**

<table><tr><td>AOL1</td><td>Aglaothamnion oosumiense lectin</td></tr><tr><td>APA</td><td>Allium porrum agglutinin</td></tr><tr><td>ASL</td><td>Agardhiella subulata lectin</td></tr><tr><td>BCA</td><td>Boodlea coacta lectin</td></tr><tr><td>BOA</td><td>Burkholderia oklahomensis agglutinin</td></tr><tr><td>BPL2</td><td>Lectin 2 of Bryopsis plumosa</td></tr><tr><td>BU14</td><td>Nannochloropsis gaditana lectin</td></tr><tr><td>CBS</td><td>Carbohydrate-binding site</td></tr><tr><td>CFA</td><td>Carpopeltis flabellata agglutinin</td></tr><tr><td>CFL</td><td>Codium fragile lectin</td></tr><tr><td>CV-N</td><td>Cyanovirin-N (Nostoc ellipsosporum)</td></tr><tr><td>EEA</td><td>Eucheuma amakusanensis lectin</td></tr><tr><td>ECA</td><td>Eucheuma cottonii lectin</td></tr><tr><td>EDA</td><td>Eucheuma denticulatum lectin</td></tr><tr><td>EPL</td><td>Enteromorpha prolifera lectin</td></tr><tr><td>ESA</td><td>Eucheuma serra lectin</td></tr><tr><td>FRIL</td><td>Flt3 receptor interacting lectin from hyacinth bean (Lablab purpureus)</td></tr><tr><td>Fuc</td><td>Fucose</td></tr><tr><td>Gal</td><td>Galactose</td></tr><tr><td>GalNAc</td><td>N-acetylgalactosamine</td></tr><tr><td>GBPL</td><td>Gracilaria bursa-pastoris lectin</td></tr><tr><td>GCL</td><td>Grateloupia chiangii lectin</td></tr><tr><td>GlcNAc</td><td>N-acetylglycosamine</td></tr><tr><td>GNA</td><td>Galanthus nivalis (snowdrop) agglutinin</td></tr><tr><td>GPT</td><td>Glycoprotein trimer</td></tr><tr><td>GRFT</td><td>Griffithsin</td></tr><tr><td>GTL</td><td>Gracilaria tikvahiae lectin</td></tr><tr><td>HFA</td><td>Hydropuntia (Gracilaria) fisheri agglutinin</td></tr><tr><td>HIV-1</td><td>Human Immunodeficiency Virus</td></tr><tr><td>HRL40</td><td>Halimeda renschii lectin</td></tr><tr><td>KAA-2</td><td>Lectin 2 of Kappaphycus alvarezii</td></tr><tr><td>KSA-2</td><td>Lectin 2 of Kappaphycus striatum</td></tr><tr><td>Man</td><td>Mannose</td></tr><tr><td>MEL</td><td>Meristiella echinocarpa lectin</td></tr><tr><td>MPL</td><td>Meristotheca papulosa agglutinin</td></tr><tr><td>MVL</td><td>Microcystis viridis lectin</td></tr><tr><td>MVN</td><td>Microvirin (Microcystis aeruginosa)</td></tr><tr><td>Neu5Ac</td><td>N-acetylneuraminic acid (sialic acid)</td></tr><tr><td>OAA</td><td>Oscillatoria agardhii lectin</td></tr></table>
OtL *Ostreococcus tauri* lectin

PDB Protein Data Bank

PPL *Palmaria palmata* lectin

PUL *Porphyra umbilicalis* lectin

RBD Receptor binding domain

SARS-CoV-2 Severe acute respiratory syndrome-coronavirus

Sia Sialic acid

ScL *Solieria chordalis* lectin

SfL *Solieria filiformis* lectin

SrL *Solieria robusta* lectin

SVN Scytovirin (*Scytonema varium*)

T/Tn T and Tn antigens (Thomsen Friedenreich antigens)

References

1. Boyd, W.C.; Almodóvar, L.R.; Boyd, L.G. Agglutinins in Marine Algae for Human Erythrocytes. *Transfusion* **1966**, *6*, 82–83. [CrossRef]

2. Blunden, G.; Rogers, D.J.; Farnham, W.F. Survey of British Seaweeds for Hæmagglutinins. *Lloydia* **1975**, *36*, 162–168.

3. Hori, K.; Ikegami, S.; Miyazawa, K.; Ito, K. Mitogenic and Antineoplastic Isoagglutinins from the Red Alga *Solieria robusta*. *Phytochemistry* **1988**, *27*, 2063–2067. [CrossRef]

4. Sugahara, T.; Ohama, Y.; Fukuda, A.; Hayashi, M.; Kawakubo, A.; Kato, K. The Cytotoxic Effect of *Eucheuma serrata* Agglutinin (ESA) on Cancer Cells and Its Application to Molecular Probe for Drug Delivery System Using Lipid Vesicles. *Cytotechnology* **2001**, *36*, 93–99. [CrossRef] [PubMed]

5. Fukuda, Y.; Sugahara, T.; Ueno, M.; Fukuta, Y.; Ochi, Y.; Akiyama, K.; Miyazaki, T.; Masuda, S.; Kawakubo, A.; Kato, K. The Anti-Tumor Effect of *Eucheuma serrata* Agglutinin on Colon Cancer Cells In Vitro and In Vivo. *Anticancer Drugs* **2006**, *17*, 943–947. [CrossRef]

6. Hayashi, K.; Walde, P.; Miyazaki, T.; Sakayama, K.; Nakamura, A.; Kameda, K.; Masuda, S.; Umakoshi, H.; Kato, K. Active Targeting to Osteosarcoma Cells and Apoptotic Cell Death Induction by the Novel Lectin *Eucheuma serrata* Agglutinin Isolated from a Marine Red Alga. *J. Drug Deliv.* **2012**, *2012*, 1–11. [CrossRef]

7. Chaves, R.P.; Da Silva, S.R.; Neto, L.G.N.; Carneiro, R.F.; Da Silva, A.L.C.; Sampaio, A.H.; De Sousa, B.L.; Cabral, M.G.; Videira, P.A.; Teixeira, E.H.; et al. Structural Characterization of Two Isolectins From the Marine Red Alga *Solieria iliformis* (Kützing) P.W. Gabrielson and Their Anticancer Effect on MCF-7 Breast Cancer Cells. *Int. J. Biol. Macromol.* **2018**, *107*, 1320–1329. [CrossRef]

8. Mori, T.; O'Keefe, B.R.; Sowder, R.C.; Bringans, S.; Gardella, R.; Berg, S.; Cochran, P.; Turpin, J.A.; Buckheit, R.; McMahon, J.B.; et al. Isolation and Characterization of Griffithsin, a Novel HIV-Inactivating Protein, from the Red Alga *Griffithsia* sp. *J. Biol. Chem.* **2004**, *280*, 9345–9353. [CrossRef]

9. Ziółkowska, N.E.; Wlodawer, A. Structural Studies of Algal Lectins with Anti-HIV Activity. *Acta Biochim. Pol.* **2006**, *53*, 617–626. [CrossRef]

10. Sato, Y.; Morimoto, K.; Hirayama, M.; Hori, K. High Mannose-Specific Lectin (KAA-2) From the Red Alga *Kappaphycus alvarezii* Potently Inhibits Influenza Virus Infection in a Strain-Independent Manner. *Biochem. Biophys. Res. Commun.* **2011**, *405*, 291–296. [CrossRef]

11. Sato, Y.; Hirayama, M.; Morimoto, K.; Yamamoto, N.; Okuyama, S.; Hori, K. High Mannose-binding Lectin with Preference for the Cluster of α1-2-Mannose from the Green Alga *Boodlea coacta* Is a Potent Entry Inhibitor of HIV-1 and Influenza Viruses. *J. Biol. Chem.* **2011**, *286*, 19446–19458. [CrossRef] [PubMed]

12. Sato, Y.; Morimoto, K.; Kubo, T.; Sakaguchi, T.; Nishizono, A.; Hirayama, M.; Hori, K. Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga *Eucheuma serrata* through the Recognition of Viral Hemagglutinin. *Mar. Drugs* **2015**, *13*, 3454–3465. [CrossRef]

13. Hirayama, M.; Shibata, H.; Imamura, K.; Sakaguchi, T.; Hori, K. High-Mannose Specific Lectin and Its Recombinants from Carrageenophyte Kappaphycus Alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120. *Mar. Biotechnol.* **2016**, *18*, 144–160. [CrossRef] [PubMed]
14. Mu, J.; Hirayama, M.; Sato, Y.; Morimoto, K.; Hori, K. A Novel High-Mannose Specific Lectin from the Green Alga Halimeda renschii Exhibits a Potent Anti-Influenza Virus Activity through High-Affinity Binding to the Viral Hemagglutinin. *Mar. Drugs* **2017**, *15*, 255. [CrossRef] [PubMed]

15. Hwang, H.-J.; Han, J.-W.; Jeon, H.; Cho, K.; Kim, J.-H.; Lee, D.-S.; Han, J.W. Characterization of a Novel Mannose-Binding Lectin with Antiviral Activities from Red Alga, *Grateloupia chiangii*. *Biomolecules* **2020**, *10*, 333. [CrossRef] [PubMed]

16. Sato, Y.; Okuyama, S.; Hori, K. Primary Structure and Carbohydrate Binding Specificity of a Potent Anti-HIV Lectin Isolated from the Filamentous Cyanobacterium, *Oscillatoria agardhii*. *J. Biol. Chem.* **2007**, *282*, 11021–11029. [CrossRef] [PubMed]

17. Boyd, M.R.; Gustafson, K.R.; McMahon, J.B.; Shoemaker, R.H.; O'Keefe, B.R.; Mori, T.; Gulakowski, R.J.; Wu, L.; Rivera, M.I.; Laurencot, C.M.; et al. Discovery of Cyanovirin-N, a Novel Human Immunodeficiency Virus-Inactivating Protein That Binds Viral Surface Envelope Glycoprotein gp120: Potential Applications to Microbicide Development. *Antimicrob. Agents Chemother.* **1997**, *41*, 1521–1530. [CrossRef]

18. Dey, B.; Lerner, D.L.; Lusso, P.; Boyd, M.R.; Elder, J.H.; Berger, E.A. Multiple Antiviral Activities of Cynovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses. *J. Virol.* **2000**, *74*, 4562–4569. [CrossRef]

19. Barrientos, L.G.; O'Keefe, B.R.; Bray, M.; Sanchez, A.; Gronenborn, A.M.; Boyd, M.R. Cyanovirin-N Binds to the Viral Surface Glycoprotein, GP₁₂ and Inhibits Infectivity of Ebola Virus. *Antivir. Res.* **2003**, *58*, 47–56. [CrossRef]

20. Helle, F.; Wychowski, C.; Vu-Dac, N.; Gustafson, K.R.; Voisset, C.; Dubuisson, J. Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans. *J. Biol. Chem.* **2006**, *281*, 25177–25183. [CrossRef]

21. O'Keefe, B.R.; Smee, D.F.; Turpin, J.A.; Saucedo, C.J.; Gustafson, K.R.; Mori, T.; Blakeslee, D.; Buckheit, R.; Boyd, M.R. Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin. *Antimicrob. Agents Chemother.* **2003**, *47*, 2518–2525. [CrossRef]

22. Huskens, D.; Férir, G.; Vermeire, K.; Kehr, J.-C.; Balzarini, J.; Dittmann, E.; Schols, D. Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from *Microcystis aeruginosa*, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile. *J. Biol. Chem.* **2010**, *285*, 24845–24854. [CrossRef] [PubMed]

23. Bewley, C.A.; Cai, M.; Ray, S.; Ghirlando, R.; Yamaguchi, M.; Muramoto, K. New Carbohydrate Specificity and HIV-1 Fusion Blocking Activity of the Cyanobacterial Protein MVL: NMR, ITC and Sedimentation Equilibrium Studies. *J. Mol. Biol.* **2004**, *339*, 901–914. [CrossRef]

24. Bokesch, H.R.; O'Keefe, B.R.; McKee, T.C.; Pannell, L.K.; Patterson, G.M.L.; Gardella, R.S.; Sowder, R.C.; Turpin, J.; Watson, K.; Buckheit, R.W.; et al. A Potent Novel Anti-HIV Protein from the Cultured Cyanobacterium *Scytonema varium*. *Biochemistry* **2003**, *42*, 2578–2584. [CrossRef]

25. Shajahan, A.; Supekar, N.T.; Gleinich, A.S.; Azadi, P. Deducing the N- and O- Glycosylation Profile of the Spike Protein of Novel Coronavirus SARS-CoV-2. *Glycobiology* **2020**, cwaa042. [CrossRef]

26. Sanda, M.; Morrison, L.; Goldman, R. N and O Glycosylation of the SARS-CoV-2 Spike Protein. *bioRxiv* **2020**. [CrossRef]

27. Walls, A.C.; Park, Y.-J.; Tortorici, M.A.; Wall, A.; McGuire, A.T.; Veesler, D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. *Cell* **2020**, *181*, 281–292.e6. [CrossRef] [PubMed]

28. Herrera, N.G.; Morano, N.C.; Celikgil, A.; Georgiev, G.I.; Malonis, R.J.; Lee, J.H.; Tong, K.; Vergnolle, O.; Massimi, A.B.; Yen, L.Y.; et al. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis. *bioRxiv* **2020**. [CrossRef]

29. Xiong, X.; The CITIID-NIHR COVID-19 BioResource Collaboration; Qu, K.; Ciazynska, K.A.; Hosmillo, M.; Carter, A.P.; Ebrahimi, S.; Ke, Z.; Scheres, S.H.W.; Bergamaschi, L.; et al. A Thermostable, Closed SARS-CoV-2 Spike Protein Trimer. *Nat. Struct. Mol. Biol.* **2020**, *27*, 934–941. [CrossRef] [PubMed]

30. Zhou, T.; Tsybovsky, Y.; Olia, A.S.; Gorman, J.; Rapp, M.A.; Cerutti, G.; Katsamba, P.S.; Nazzari, A.; Schon, A.; Wang, P.D.; et al. A pH-Dependent Switch Mediates Conformational Masking of SARS-CoV-2 Spike. *bioRxiv* **2020**. [CrossRef]

31. Wang, Q.; Zhang, Y.; Wu, L.; Niu, S.; Song, C.; Zhang, Z.; Lu, G.; Qiao, C.; Hu, Y.; Yuen, K.-Y.; et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. *Cell* **2020**, *181*, 894–904.e9. [CrossRef] [PubMed]
32. Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S.; Schiergens, T.S.; Herrler, G.; Wu, N.-H.; Nitsche, A.; et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. *Cell* **2020**, *181*, 271–280.e8. [CrossRef] [PubMed]

33. Hoffmann, M.; Kleine-Weber, H.; Pöhlmann, S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. *Mol. Cell* **2020**, *78*, 779–784.e5. [CrossRef]

34. Li, M.-Y.; Li, L.; Zhang, Y.; Wang, X.-S. Expression of the SARS-CoV-2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues. *Infect. Dis. Poverty* **2020**, *9*, 1–7. [CrossRef] [PubMed]

35. Kumar, S.; Maurya, V.K.; Prasad, A.K.; Bhatt, M.L.B.; Saxena, S.K. Structural, Glycosylation and Antigenic Variation Between 2019 Novel Coronavirus (2019-nCov) and SARS Coronavirus (SARS-CoV). *VirusDisease* **2020**, *31*, 13–21. [CrossRef]

36. Hori, K.; Matsuda, H.; Miyazawa, K.; Ito, K. A Mitogenic Agglutinin from the Red Alga *Carpopeltis flabellata*. *Phytochemistry* **1987**, *26*, 1335–1338. [CrossRef]

37. Kawakubo, A.; Makino, H.; Ohnishi, J.-I.; Hirohara, H.; Hori, K. Occurrence of Highly Yielded Lectins Homologous Within the Genus *Eucheuma*. *J. Apppl. Phycol.* **1999**, *11*, 149–156. [CrossRef]

38. Hung, L.D.; Sato, Y.; Hori, K. High- Mannose N-Glycan-Specific Lectin from the Red Alga *Kappaphycus striatum* (Carrageenophyte). *Phytochemistry* **2011**, *72*, 855–861. [CrossRef]

39. Kawakubo, A.; Makino, H.; Ohnishi, J.-I.; Hirohara, H.; Hori, K. The Marine Red Alga *Eucheuma serra* J. Agardh, a High Yielding Source of Two Isolectins. *J. Apppl. Phycol.* **1997**, *9*, 331–338.

40. Hori, K.; Sato, Y.; Ito, K.; Fujiwara, Y.; Iwamoto, Y.; Makino, H.; Kawakubo, A. Strict Specificity for High-Mannose Type N-Glycans and Primary Structure of a Red Alga *Eucheuma serra* Lectin. *Glycobiology* **2007**, *17*, 479–491. [CrossRef] [PubMed]

41. Okamoto, R.K.; Hori, K.; Miyazawa, K.; Ito, K. Isolation and Characterisation of a New Haemagglutinin From the Red Alga *Gracilaria bursa-pastoris*. *Experientia* **1990**, *46*, 975–977. [CrossRef] [PubMed]

42. Chaves, R.P.; Da Silva, S.R.; Da Silva, J.P.F.A.; Carneiro, R.F.; De Sousa, B.L.; Abreu, J.O.; De Carvalho, F.C.T.; Rocha, C.R.C.; Farias, W.R.L.; De Sousa, O.V.; et al. *Meristiella echinocarpa* Lectin (MEL): A New Member of the OAAH-Lectin Family. *J. Appl. Phycol.* **2018**, *30*, 2629–2638. [CrossRef]

43. Suttisrisung, S.; Senapin, S.; Withyachumnarnkul, B.; Wongprasert, K. Identification and Characterization of a Novel Legume-Like Lectin cDNA Sequence from the Red Marine Algae *Gracilaria fisheri*. *J. Biosci.* **2011**, *36*, 833–843. [CrossRef] [PubMed]

44. Van Holle, S.; Damme, E.J. Messages from the Past: New Insights in Plant Lectin Evolution. *Front. Plant Sci.* **2019**, *10*, 36. [CrossRef]

45. Carpinelli, E.C.; Telatin, A.; Vitulo, N.; Forcato, C.; D'Angelo, M.; Schiavon, R.; Vezzi, A.; Giacometti, G.M.; Morosinotto, T.; Valle, G. Chromosome Scale Genome Assembly and Transcriptome Profiling of Nannochloropsis gaditana in Nitrogen Depletion. *Mol. Plant* **2014**, *7*, 323–335. [CrossRef]

46. Hori, K.; Miyazawa, K.; Ito, K. Isolation and Characterization of Glycoconjugate-Specific Isoagglutinins from a Marine Green Alga *Boodlea coacta* Murray et De Toni. *Bot. Mar.* **1986**, *29*, 323–328. [CrossRef]

47. Hwang, H.-J.; Han, J.-W.; Jeon, H.; Han, J.W. Induction of Recombinant Lectin Expression by an Artificially Constructed Tandem Repeat Structure: A Case Study Using Bryopsis plumosa Mannose-Binding Lectin. *Biomolecules* **2018**, *8*, 146. [CrossRef]

48. Ambrosio, A.L.; Sanz, L.; Sánchez, E.I.; Wolfenstein-Todel, C.; Calvete, J.J. Isolation of Two Novel Mannan-and L-Fucose-Binding Lectins from the Green Alga *Enteromorpha prolifera*: Biochemical Characterization of EPL-2. *Arch. Biochem. Biophys.* **2003**, *415*, 245–250. [CrossRef]

49. Derelle, E.; Ferraz, C.; Rombauts, S.; Rouzé, P.; Worden, A.Z.; Robbens, S.; Partensky, F.; Degroeve, S.; Echeynié, S.; Cooke, R.; et al. Genome Analysis of the Smallest Free-Living Eukaryote *Ostreococcus tauri* Unveils Many Unique Features. *Proc. Natl. Acad. Sci. USA* **2006**, *103*, 11647–11652. [CrossRef]

50. Van Damme, E.J.M.; Rougé, P.; Peumans, W. Plant Lectins. In *Protein Interactions: Plant Lectins*; Kamerling, J.P., Boons, G.J., Lee, Y.C., Suzuki, A., Taniguchi, N., Voragen, A.G.I., Eds.; Elsevier: New York, NY, USA, 2007; pp. 564–599.

51. Hardman, K.D.; Ainsworth, C.F. Structure of Concanavalin A at 2.4-Ang Resolution. *Biochemistry* **1972**, *11*, 4910–4919. [CrossRef]

52. Einspahr, H.; Parks, E.H.; Suguna, K.; Subramanian, E.; Suddath, F.L. The Crystal Structure of Pea Lectin at 3.0-A Resolution. *J. Biol. Chem.* **1986**, *261*, 16518–16527. [PubMed]
53. Loris, R.; Van Overberge, D.; Dao-Thi, M.-H.; Poortmans, F.; Maene, N.; Wyns, L. Structural Analysis of Two Crystal Forms of Lentil Lectin at 1.8 Å Resolution. *Proteins* **1994**, *20*, 330–346. [CrossRef] [PubMed]

54. Velloso, L.M.; Svensson, K.; Schneider, G.; Pettersson, R.F.; Lindqvist, Y. Crystal Structure of the Carbohydrate Recognition Domain of p58/Ergic-53, a Protein Involved in Glycoprotein Export from the Endoplasmic Reticulum. *J. Biol. Chem.* **2002**, *277*, 15979–15984. [CrossRef] [PubMed]

55. Satoh, T.; Cowieson, N.P.; Hakamata, W.; Ideo, H.; Fukushima, K.; Kurihara, M.; Kato, R.; Yamashita, K.; Wakatsuki, S. Structural Basis for Recognition of High Mannose Type Glycoproteins by Mammalian Transport Lectin VIP36. *J. Biol. Chem.* **2007**, *282*, 28246–28255. [CrossRef]

56. Han, J.W.; Klochkova, T.A.; Shim, J.B.; Yoon, K.; Kim, G.H. Isolation and Characterization of a Sex-Specific Lectin in a Marine Red Alga, *Aglaothamnion oosumiense* Itono. *Appl. Environ. Microbiol.* **2012**, *78*, 7283–7289. [CrossRef]

57. Wu, A.M.; Song, S.-C.; Hwang, P.-Y.; Wu, J.H.; Chang, K.S.S. Binding Studies on the Combining Site of a GalNAcalpha1-Specific Lectin with Thomsen-Friedenreich Activity Prepared from Green Marine Algae *Codium fragile* Subspecies Tomentosoides. *Eur. J. Biochem.* **1995**, *233*, 145–151.

58. Wu, A.M.; Song, S.-C.; Chang, S.-C.; Kabat, E. Further Characterization of the Binding Properties of a GalNAc Specific Lectin from *Codium fragile* Subspecies *tomentosoides*. *Glycobiology* **1997**, *7*, 1061–1066. [CrossRef]

59. Chiles, T.C.; Bird, K.T. Gracilaria Tikvahiae Agglutinin. Partial Purification and Preliminary Characterization of Its Carbohydrate Specificity. *Carbohydr. Res.* **1990**, *207*, 319–326. [CrossRef]

60. Kamiya, H.; Ogata, K.; Hori, K.; Hori, K.O.K. Isolation and Characterization of a New Agglutinin in the Red Alga *Palmaria palmata* (L.) O. Kuntze. *Bot. Mar.* **1982**, *25*, 537–540. [CrossRef]

61. Rogers, D.J.; Topliss, J.A. Purification and Characterization of an Anti-Sialic Acid Agglutinin from the Red Alga *Solieria chordalis* (C. Ag.). *Bot. Mar.* **1983**, *26*, 301–306. [CrossRef]

62. Criado, M.; Ferreirós, C. Selective Interaction of a *Fucus vesiculosus* Lectin-Like Mucopolysaccharide with Several Candida Species. *Ann. Inst. Pasteur Microbiol.* **1983**, *134*, 149–154. [CrossRef]

63. Ritchie, G.; Harvey, D.J.; Feldmann, F.; Stroeher, U.; Feldmann, H.; Royle, L.; Dwek, R.A.; Rudd, P.M. Identification of N- Linked Carbohydrates from Severe Acute Respiratory Syndrome (SARS) Spike Glycoprotein. *Virology* **2010**, *399*, 257–269. [CrossRef] [PubMed]

64. Yuan, M.; Wu, N.C.; Zhu, X.; Lee, C.-C.D.; So, R.T.Y.; Lv, H.; Mok, C.K.P.; Wilson, I.A. A Highly Conserved Cryptic Epitope in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV. *Science* **2020**, *368*, 630–633. [CrossRef]

65. Yuan, M.; Liu, H.; Wu, N.C.; Lee, C.-C.D.; Zhu, X.; Zhao, F.; Huang, D.; Yu, W.; Hua, Y.; Tien, H.; et al. Structural Basis of a Public Antibody Response to SARS-CoV-2. *bioRxiv* **2020**. [CrossRef]

66. Hansen, J.; Baum, A.; Pascal, K.E.; Russo, V.; Giordano, S.; Wloga, E.; Fulton, B.O.; Yan, Y.; Koon, K.; Patel, K.; et al. Studies in Humanized Mice and Convalescent Humans Yield a SARS-CoV-2 Antibody Cocktail. *Science* **2020**, eabd0827. [CrossRef]

67. Hurlburt, N.K.; Wan, Y.-H.; Stuart, A.B.; Feng, J.; McGuire, A.T.; Stamatatos, L.; Pancera, M. Structural Basis for Potent Neutralization of SARS-Cov-2 and Role of Antibody Affinity Maturation. *bioRxiv* **2020**. [CrossRef]

68. Zhou, D.; Duyvesteyn, H.M.E.; Chen, C.-P.; Huang, C.-G.; Chen, T.-H.; Shih, S.-R.; Lin, Y.-C.; Cheng, C.-Y.; Cheng, S.-H.; Huang, Y.-C.; et al. Structural Basis for the Neutralization of SARS-Cov-2 by an Antibody from a Convalescent Patient. *Nat. Struct. Mol. Biol.* **2020**. [CrossRef]

69. Ju, B.; Zhang, Q.; Ge, J.; Wang, R.; Sun, J.; Ge, X.; Yu, J.; Shan, S.; Zhou, B.; Song, S.; et al. Human Neutralizing Antibodies Elicited by SARS-CoV-2 Infection. *Nat. Cell Biol.* **2020**, *584*, 115–119. [CrossRef]

70. Wu, Y.; Wang, F.; Shen, C.; Peng, W.; Li, D.; Zhao, C.; Li, Z.; Li, S.; Bi, Y.; Yang, Y.; et al. A Noncompeting Pair of Human Neutralizing Antibodies Block COVID-19 Virus Binding to Its Receptor ACE2. *Science* **2020**, *368*, 1274–1278. [CrossRef]

71. Shi, R.; Shan, C.; Duan, X.; Chen, Z.; Liu, P.; Song, J.; Song, T.; Bi, X.; Wu, L.; Gao, G.; et al. A Human Neutralizing Antibody Targets the Receptor-Binding Site of SARS-CoV-2. *Nat. Cell Biol.* **2020**, *584*, 120–124. [CrossRef]

72. Wu, N.C.; Yuan, M.; Liu, H.; Lee, C.C.D.; Zhu, X.; Bangaru, S.; Torres, J.L.; Caniels, T.G.; Brouwer, P.J.M.; van Gils, M.J.; et al. An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain. *Cell Rep.* **2020**, *33*, 108274. [CrossRef]
73. Pinto, D.; Park, Y.-J.; Beltramello, M.; Walls, A.C.; Tortorici, M.A.; Bianchi, S.; Jaconi, S.; Culap, K.; Zatta, F.; De Marco, A.; et al. Structural and Functional Analysis of a Potent Sarbecovirus Neutralizing Antibody. *bioRxiv* **2020**. [CrossRef]

74. Henderson, R.; Edwards, R.J.; Mansouri, K.; Janowska, K.; Stalls, V.; Gobeil, S.; Kopp, M.; Li, D.; Parks, R.; Hsu, A.L.; et al. Controlling the SARS-CoV-2 Spike Glycoprotein Conformation. *Nat. Struct. Mol. Biol.* **2020**, *1–9*. [CrossRef]

75. McCallum, M.; Walls, A.C.; Bowen, J.E.; Corti, D.; Veesler, D. Structure-Guided Covalent Stabilization of Coronavirus Spike Glycoprotein Trimers in the Closed Conformation. *Nat. Struct. Mol. Biol.* **2020**, *27*, 942–949. [CrossRef] [PubMed]

76. Barnes, C.O.; West, A.P.; Huey-Tubman, K.E.; Hoffmann, M.A.; Sharaf, N.G.; Hoffman, P.R.; Koranda, N.; Gristick, H.B.; Gaebler, C.; Muecksch, F.; et al. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. *Cell* **2020**, *182*, 828–842.e16. [CrossRef] [PubMed]

77. Liu, L.; Wang, P.; Nair, M.S.; Yu, J.; Rapp, M.; Wang, Q.; Luo, Y.; Chan, J.F.-W.; Sahi, V.; Figueroa, A.; et al. Potent Neutralizing Antibodies Against Multiple Epitopes on SARS-CoV-2 Spike. *Nat. Cell Biol.* **2020**, *584*, 450–456. [CrossRef] [PubMed]

78. Hsieh, C.-L.; Goldsmith, J.A.; Schaub, J.M.; DiVenere, A.M.; Kuo, H.-C.; Javanmardi, K.; Le, K.C.; Wrapp, D.; Lee, A.G.; Liu, Y.; et al. Structure-Based Design of Prefusion-Stabilized SARS-CoV-2 Spikes. *Science* **2020**, *369*, 1501–1505. [CrossRef]

79. Chi, X.; Yan, R.; Zhang, J.; Zhang, G.; Zhang, Y.; Hao, M.; Zhang, Z.; Fan, P.; Dong, Y.; Yang, Y.; et al. A Neutralizing Human Antibody Binds to the N-Terminal Domain of the Spike Protein of SARS-CoV-2. *Science* **2020**, *369*, 650–655. [CrossRef]

80. Yurkovetskiy, L.; Pascal, K.E.; Tompkins-Tinch, C.; Nyalile, T.; Wang, Y.; Baum, A.; Diehl, W.E.; Dauphin, A.; Carbone, C.; Veinotte, K.; et al. SARS-CoV-2 Spike Protein Variant D614G Increases Infectivity and Retains Sensitivity to Antibodies That Target the Receptor Binding Domain. *bioRxiv* **2020**. [CrossRef]

81. Huo, J.; Zhao, Y.; Ren, J.; Zhou, D.; Duyvesteyn, H.M.E.; Ginn, H.M.; Carrique, L.; Malinauskas, T.; Ruza, R.R.; Shah, P.N.; et al. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. *Cell Host Microbe* **2020**, *30351–30356*. [CrossRef]

82. Melero, R.; Sorzano, C.O.S.; Foster, B.; Vilas, J.-L.; Martínez, M.; Marabini, R.; Ramírez-Aportela, E.; Sanchez-Garcia, R.; Herreros, D.; Del Caño, L.; et al. Continuous Flexibility Analysis of SARS-Cov-2 Spike Prefusion Structures. *IUCR* **2020**, *7*. [CrossRef]

83. Ke, Z.; Oton, J.; Qu, K.; Cortese, M.; Zila, V.; McKeane, L.; Nakane, T.; Zivanov, J.; Neufeldt, C.J.; Cerikan, B.; et al. Structures and Distributions of SARS-Cov-2 Spike Proteins on Intact Virions. *Nat. Cell Biol.* **2020**, *1–7*. [CrossRef]

84. Cao, Y.; Su, B.; Guo, X.; Sun, W.; Deng, Y.; Bao, L.; Zhu, Q.; Zhang, X.; Zheng, Y.; Geng, C.; et al. Potent Neutralizing Antibodies Against Sars-Cov-2 Identified by High-Throughput Single-Cell Sequencing of Covalescent Patients’ B Cells. *Cell* **2020**, *182*, 73–84. [PubMed]

85. Liu, Y.-M.; Mahmud, S.-A.; Chen, X.; Chen, T.-H.; Liao, K.-S.; Lo, J.M.; Wu, Y.-M.; Ho, M.-C.; Wu, C.-Y.; Wong, C.-H.; et al. A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2. *Cell Rep.* **2020**, *32*, 108016. [CrossRef] [PubMed]

86. Bangaru, S.; Ozorowski, G.; Turner, H.L.; Antanasijevic, A.; Huang, D.; Wang, X.; Torres, J.L.; Diedrich, J.K.; Tian, J.-H.; Portnoff, A.D.; et al. Structural Analysis of Full-Length SARS-CoV-2 Spike Protein from an Advanced Vaccine Candidate. *Science* **2020**, eabe1502. [CrossRef]

87. Ziółkowska, N.E.; O'Keefe, B.R.; Mori, T.; Zhu, C.; Giomarelli, B.; Vojdani, F.; Palmer, K.E.; McMahon, J.B.; Wlodawer, A. Domain-Swapped Structure of the Potent Antiviral Protein Griffithsin and Its Mode of Carbohydrate Binding. *Structure* **2006**, *14*, 1127–1135. [CrossRef]

88. Ziółkowska, N.E.; Shenoy, S.R.; O'Keefe, B.R.; McMahon, J.B.; Palmer, K.E.; Dwek, R.A.; Wormald, M.R.; Wlodawer, A. Crystallographic, Thermodynamic, and Molecular Modeling Studies of the Mode of Binding of Oligosaccharides to the Potent Antiviral Protein Griffithsin. *Proteins* **2007**, *67*, 661–670. [CrossRef]

89. Moulaei, T.; Shenoy, S.R.; Giomarelli, B.; Thomas, C.; McMahon, J.B.; Dauter, Z.; O'Keefe, B.R.; Wlodawer, A. Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and Anti-HIV Activity. *Structure* **2010**, *18*, 1104–1115. [CrossRef]
90. Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, N.; Bourne, P.E. The Protein Data Bank. *Nucleic Acids Res.* **2000**, *28*, 235–242. [CrossRef]

91. Whitley, M.J.; Furey, W.; Kollipara, S.; Gronenborn, A.M. Burkholderia Oklahomensisagglutinin Is a Canonical Two-Domain OAA-Family Lectin: Structures, Carbohydrate Binding and Anti-HIV Activity. *FEBS J.* **2013**, *280*, 2056–2067. [CrossRef]

92. Koharudin, L.M.; Gronenborn, A.M. Structural Basis of the Anti-HIV Activity of the Cyanobacterial *Oscillatoria agardhii* Agglutinin. *Structure* **2011**, *19*, 1170–1181. [CrossRef] [PubMed]

93. Krieger, E.; Koraimann, G.; Vriend, G. Increasing the Precision of Comparative Models with Yasara Nova—A Self-Parametrizing Force Field. *Proteins* **2002**, *47*, 393–402. [CrossRef] [PubMed]

94. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK: A Program to Check the Stereochemistry of Protein Structures. *J. Appl. Crystallogr.* **1993**, *126*, 283–291. [CrossRef]

95. Melo, F.; Feytmans, E. Assessing Protein Structures with a Non-Local Atomic Interaction Energy. *J. Mol. Biol.* **1998**, *277*, 1141–1152. [CrossRef] [PubMed]

96. Benkert, P.; Biasini, M.; Schwede, T. Toward the Estimation of the Absolute Quality of Individual Protein Structure Models. *Bioinformatics* **2010**, *27*, 343–350. [CrossRef] [PubMed]

97. Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The SWISS-MODEL Workspace: A Web-Based Environment for Protein Structure Homology Modelling. *Bioinformatics* **2005**, *22*, 195–201. [CrossRef] [PubMed]

98. Grosdidier, A.; Zoete, V.; Michielin, O. SwissDock, A Protein-Small Molecule Docking Web Service Based on EADock DSS. *Nucleic Acids Res.* **2011**, *39*, W270–W277. [CrossRef]

99. Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera—A Visualization System for Exploratory Research and Analysis. *J. Comput. Chem.* **2004**, *25*, 1605–1612. [CrossRef]

100. O'Keefe, B.R.; Giomarelli, B.; Barnard, D.L.; Shenoy, S.R.; Chan, P.K.S.; McMahon, J.B.; Palmer, K.E.; Barnett, B.W.; Meyerholz, D.K.; Wohlford-Lenane, C.L.; et al. Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae. *J. Virol.* **2010**, *84*, 5456. [CrossRef]

101. Millet, J.K.; Séron, K.; Labitt, R.N.; Danneels, A.; Palmer, K.E.; Whittaker, G.R.; Dubuisson, J.; Belouzard, S. Middle East Respiratory Syndrome Coronavirus Infection Is Inhibited by Griffithsin. *Antivir. Res.* **2016**, *133*, 1–8. [CrossRef]

102. Keyaerts, E.; Vijgen, L.; Pannecouque, C.; Van Damme, E.; Peumans, W.; Egberink, H.; Balzarini, J.; Van Ranst, M. Plant Lectins Are Potent Inhibitors of Coronaviruses by Interfering with Two Targets in the Viral Replication Cycle. *Antivir. Res.* **2007**, *75*, 179–187. [CrossRef] [PubMed]

103. Mani, J.S.; Johnson, J.B.; Steel, J.C.; Broszczak, D.A.; Neilsen, P.M.; Walsh, K.B.; Naiker, M. Natural Product-Derived Phytochemicals as Potential Agents Against Coronaviruses: A Review. *Virus Res.* **2020**, *284*, 197–989. [CrossRef] [PubMed]

104. Rosales-Mendoza, S.; García-Silva, I.; González-Ortega, O.; Sandoval-Vargas, J.M.; Malla, A.; Vimolmangkang, S. The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals. *Molecules* **2020**, *25*, 4049. [CrossRef] [PubMed]

105. Sohrab, S.S.; Suhail, M.; Kamal, M.A.; Ahmad, F.; Azhar, E.I. Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2. *Curr. Pharm. Des.* **2020**, *26*, 1–10. [CrossRef]

106. Gupta, R.K.; Apte, G.R.; Lokhande, K.B.; Mishra, S.; Pal, J.K. Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy. *Curr. Protein Pept. Sci.* **2020**, *21*, 1–13. [CrossRef]

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

<figure><img src="image_18.png" /></figure>

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).